I migliori radiologi di medicina nucleare di Medicina nucleare a Ramat Gan - TOP-5 medici

Neurosurgeon | Director of Neurosurgery Department | Neuro-Oncology Expert

Included in Forbes Israel’s “Best Doctors” List (2025)

Areas of Expertise

Professor Zvi Cohen specializes in advanced neurosurgery and neuro-oncology, focusing on both benign and malignant tumors of the central nervous system:

Malignant Brain Tumors

Comprehensive surgical and multidisciplinary treatment

Benign Brain Tumors

Precision microsurgical and minimally invasive approaches

Pituitary Adenomas

Advanced surgical management using modern techniques

Spinal and Spinal Cord Tumors

Surgical treatment of primary and metastatic lesions

Brain Metastases

Image-guided tumor resection and radiosurgical strategies

Neurosurgery

Full spectrum of complex cranial and spinal procedures

About the Doctor

Professor Zvi Cohen is a leading neurosurgeon and neuro-oncology specialist, serving as the Director of the Neurosurgery Department at Sheba Medical Center.

He also leads clinical research initiatives within the department, focusing on evaluating the effectiveness of modern pharmacological therapies for malignant brain tumors.

Prof. Cohen has extensive experience in performing complex neurosurgical procedures, including surgeries for tumors of the brain, spine, and spinal cord.

His surgical expertise includes:

frame-based and frameless stereotactic brain biopsies

image-guided tumor resection

use of intraoperative MRI for maximum precision and safety

He is also the founder of the brain tumor tissue bank at Sheba Medical Center, contributing to ongoing advancements in neuro-oncology research.

Clinical Approach

Professor Cohen applies a highly precise, technology-driven, and multidisciplinary approach, combining surgery with advanced imaging and oncology expertise.

His priorities include:

maximal tumor removal with functional preservation

minimizing neurological deficits

use of cutting-edge technologies (intraoperative MRI, navigation systems)

integration of surgery with systemic and targeted therapies

Positions

Director, Department of Neurosurgery, Sheba Medical Center

Director, Neuro-Oncology Unit

Deputy Director, Department of Neurosurgery

Assistant Professor of Neurosurgery, Tel Aviv University

Education and Training

MD, School of Medicine, Tel Aviv University, Israel

Residency in Neurosurgery, Sheba Medical Center

Fellowship in Neuroradiology, Beth Israel Medical Center, USA

Fellowship in Neurosurgical Oncology, MD Anderson Cancer Center, Houston, USA

Board Certifications

Neurosurgery

Professional Memberships

Member of Society for Neuro-Oncology

Member of Israeli Association of Neurological Surgeons

Research & Publications

Professor Cohen is actively involved in clinical and translational research in neuro-oncology and has contributed to multiple scientific publications, including:

The impact of intraoperative neurophysiological monitoring on outcomes in spinal tumors

Radiosurgery approaches for brain metastases and associated cerebral edema

His work supports continuous improvement in surgical precision and patient outcomes in complex neurosurgical oncology

Einat Shacham-Shmueli, MD

Medical Oncologist | Gastrointestinal Cancer Specialist

Areas of Expertise

Dr. Einat Shacham-Shmueli specializes in medical oncology, with a primary focus on gastrointestinal malignancies and advanced cancer management:

Gastrointestinal Cancers (colon, stomach, pancreas, etc.)

Clinical Oncology & Medical Oncology

Cancer Diagnostics and Biomarkers

Tumor Biology

Metastatic Disease Management

Radiotherapy Integration in Cancer Treatment

About the Doctor

Dr. Einat Shacham-Shmueli is a senior medical oncologist at the Gastrointestinal Clinic of the Cancer Center at Sheba Medical Center.

She specializes in the treatment of gastrointestinal cancers, providing personalized, evidence-based care tailored to each patient’s condition. Her clinical work combines advanced systemic therapies, precision diagnostics, and multidisciplinary treatment planning.

Dr. Shacham-Shmueli has authored over 25 scientific publications, contributing to ongoing research in oncology, including tumor biology, biomarkers, and treatment strategies for complex cancer cases.

Clinical Approach

Personalized treatment strategies based on tumor biology and biomarkers

Integration of systemic therapy with radiotherapy and other modalities

Multidisciplinary collaboration for optimal outcomes

Focus on both treatment effectiveness and quality of life

Positions

Senior Oncologist, Gastrointestinal Clinic, Cancer Center, Sheba Medical Center

Investigator in international oncology research programs, including:

National Cancer Institute (NCI)

Radiation Therapy Oncology Group

Cancer Therapy Evaluation Program

Member of the Israel Society of Oncology and Radiotherapy

Education and Training

MD, School of Medicine, Tel Aviv University, Israel

Residency in Oncology, Tel Aviv Sourasky Medical Center, Israel

Advanced training in Gastrointestinal Oncology, University of California, San Francisco, USA

Board Certifications

Oncology

Gastroenterology

Research & Publications

Dr. Shacham-Shmueli has published extensively in the field of oncology, with over 25 peer-reviewed articles focusing on gastrointestinal cancers, tumor biology, and innovative treatment approaches.

Selected topic:

Stenting in malignant colonic obstruction

Jair Bar, MD, PhD, Professor

Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist

Areas of Expertise

Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:

Lung Cancer (non-small cell and advanced stages)

Thoracic Oncology

Medical Oncology & Radiotherapy

Molecular Biology & Genetics in Cancer

Immunotherapy and Resistance Mechanisms

Translational Oncology Research

About the Doctor

Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.

He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.

In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.

He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.

Clinical Approach

Personalized cancer treatment based on molecular and genetic profiling

Integration of immunotherapy, targeted therapy, and radiotherapy

Multidisciplinary decision-making for complex cases

Focus on improving survival outcomes and quality of life

Positions

Deputy Director, Cancer Center, Sheba Medical Center

Head of Thoracic Oncology Unit

Chair, Israel Lung Cancer Group (since 2003)

Senior Lecturer, Tel Aviv University

Professional Memberships

Member of Israel Society of Clinical Oncology and Radiotherapy

Member of American Society of Clinical Oncology

Member of American Association for Cancer Research

Education and Training

MD, Hebrew University of Jerusalem (Hadassah Medical School)

PhD in Molecular Biology, Weizmann Institute of Science

Board Certifications

Medical Oncology

Radiotherapy Oncology

Research & Publications

Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:

Cancer metabolism in lung cancer based on exhaled breath analysis

Angiogenesis inhibition strategies in lung cancer therapy

He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.